Atlas Trials

Safety, Tolerability, Efficacy of MTP-131 for Treatment of Mitochondrial Disease in Subjects From the MMPOWER Study

Clinical trial NCT02805790 · COMPLETED

Trial details

NCT number
NCT02805790
Sponsor
Stealth BioTherapeutics Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Primary Mitochondrial Disease
Start date
2016-08-22
Primary completion
2017-03-10
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.